US HB447 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 27-0)
Status: Introduced on January 10 2019 - 25% progression
Action: 2019-01-10 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 10 2019 - 25% progression
Action: 2019-01-10 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Affordable and Safe Prescription Drug Importation Act
Title
Affordable and Safe Prescription Drug Importation Act
Sponsors
| Rep. Elijah Cummings [D-MD] | Rep. Lloyd Doggett [D-TX] | Rep. Peter Welch [D-VT] | Rep. Steve Cohen [D-TN] |
| Rep. Ro Khanna [D-CA] | Rep. Barbara Lee [D-CA] | Rep. Eleanor Norton [D-DC] | Rep. Chellie Pingree [D-ME] |
| Rep. Rosa DeLauro [D-CT] | Rep. Brad Sherman [D-CA] | Rep. Mark Pocan [D-WI] | Rep. Pramila Jayapal [D-WA] |
| Rep. Ilhan Omar [D-MN] | Rep. Raja Krishnamoorthi [D-IL] | Rep. Tulsi Gabbard [D-HI] | Rep. James Langevin [D-RI] |
| Rep. Sheila Jackson-Lee [D-TX] | Rep. Earl Blumenauer [D-OR] | Rep. Janice Schakowsky [D-IL] | Rep. Joseph Neguse [D-CO] |
| Rep. Alexandria Ocasio-Cortez [D-NY] | Rep. Rashida Tlaib [D-MI] | Rep. Mark DeSaulnier [D-CA] | Rep. Debra Haaland [D-NM] |
| Rep. Jamie Raskin [D-MD] | Rep. Grace Napolitano [D-CA] | Rep. John Garamendi [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-01-10 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-01-10 | House | Introduced in House |
Same As/Similar To
SB97 (Same As) 2019-01-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Canada
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Prescription drugs
Trade restrictions
User charges and fees
Canada
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Prescription drugs
Trade restrictions
User charges and fees
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/447/all-info |
| Text | https://www.congress.gov/116/bills/hr447/BILLS-116hr447ih.pdf |
